For: | Del Carpio-Orantes L. Etiopathogenic theories about long COVID. World J Virol 2023; 12(3): 204-208 [PMID: 37396704 DOI: 10.5501/wjv.v12.i3.204] |
---|---|
URL: | https://www.wjgnet.com/2220-3249/full/v12/i3/204.htm |
Number | Citing Articles |
1 |
Matthew W. McCarthy. Paxlovid as a potential treatment for long COVID. Expert Opinion on Pharmacotherapy 2023; 24(17): 1839 doi: 10.1080/14656566.2023.2262387
|
2 |
Luis Del Carpio-Orantes, Andrés Aguilar-Silva, Sergio García-Méndez, Jesús Salvador Sánchez-Diaz, Yamir Rodríguez-Contreras, Estefanía Lara-Hernández, Daniela Fernández-Márquez. Neuropsychiatric manifestations in patients with long COVID in Mexico. Brain Circulation 2023; 9(3): 196 doi: 10.4103/bc.bc_13_23
|
3 |
Matthew W. McCarthy. Intravenous immunoglobulin as a potential treatment for long COVID. Expert Opinion on Biological Therapy 2023; 23(12): 1211 doi: 10.1080/14712598.2023.2296569
|
4 |
Isaac Núñez, Joshua Gillard, Sergio Fragoso-Saavedra, Dorien Feyaerts, León Islas-Weinstein, Angel A. Gallegos-Guzmán, Uriel Valente-García, Justin Meyerowitz, J. Daniel Kelly, Han Chen, Edward Ganio, Alexander Benkendorff, Jaime Flores-Gouyonnet, Pedro Dammann-Beltrán, José Francisco Heredia-González, Gabriela A. Rangel-Gutiérrez, Catherine A. Blish, Kari C. Nadeau, Garry Nolan, Jose C. Crispín, David R. McIlwain, Brice Gaudillière, Sergio I. Valdés-Ferrer. Longitudinal clinical phenotyping of post COVID condition in Mexican adults recovering from severe COVID-19: a prospective cohort study. Frontiers in Medicine 2023; 10 doi: 10.3389/fmed.2023.1236702
|